214 related articles for article (PubMed ID: 32260165)
21. Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients.
Mazdak M; Ringlstetter R; Tabrizi PF; Akkoyun M; Wolters M; Schmitz J; Bräsen JH; Peters I; Kuczyk MA; Tezval H
Adv Ther; 2021 Jun; 38(6):3373-3388. PubMed ID: 34021481
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
Rotellini M; Palomba A; Baroni G; Franchi A
Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
[TBL] [Abstract][Full Text] [Related]
24. PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva.
Czogalla B; Pham D; Trillsch F; Rottmann M; Gallwas J; Burges A; Mahner S; Kirchner T; Jeschke U; Mayr D; Schmoeckel E
J Cancer Res Clin Oncol; 2020 Mar; 146(3):569-577. PubMed ID: 32025868
[TBL] [Abstract][Full Text] [Related]
25. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
26. The expression of programed death ligand-1 could be related with unfavorable prognosis in salivary duct carcinoma.
Sato F; Akiba J; Kawahara A; Naito Y; Ono T; Takase Y; Murata K; Abe H; Yamaguchi T; Miyoshi H; Abe Y; Mihara Y; Tanikawa M; Akashi M; Kurose H; Umeno H; Yano H
J Oral Pathol Med; 2018 Aug; 47(7):683-690. PubMed ID: 29719073
[TBL] [Abstract][Full Text] [Related]
27. Salivary gland epithelial neoplasms in pediatric population: a single-institute experience with a focus on the histologic spectrum and clinical outcome.
Xu B; Aneja A; Ghossein R; Katabi N
Hum Pathol; 2017 Sep; 67():37-44. PubMed ID: 28739497
[TBL] [Abstract][Full Text] [Related]
28. Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin.
Prabhu S; Kaveri H; Rekha K
Oral Oncol; 2009 Jul; 45(7):594-9. PubMed ID: 18955011
[TBL] [Abstract][Full Text] [Related]
29. Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC.
Ulas EB; Hashemi SMS; Houda I; Kaynak A; Veltman JD; Fransen MF; Radonic T; Bahce I
JTO Clin Res Rep; 2023 Sep; 4(9):100532. PubMed ID: 37681219
[TBL] [Abstract][Full Text] [Related]
30. Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands.
Mosconi C; de Arruda JAA; de Farias ACR; Oliveira GAQ; de Paula HM; Fonseca FP; Mesquita RA; Silva TA; Mendonça EF; Batista AC
Oral Oncol; 2019 Jan; 88():95-101. PubMed ID: 30616805
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
Abd Raboh NM; Hakim SA
Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
[TBL] [Abstract][Full Text] [Related]
32. PD-L1 expression in malignant salivary gland tumors.
Harada K; Ferdous T; Ueyama Y
BMC Cancer; 2018 Feb; 18(1):156. PubMed ID: 29409471
[TBL] [Abstract][Full Text] [Related]
33. HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-Analysis.
Egebjerg K; Harwood CD; Woller NC; Kristensen CA; Mau-Sørensen M
Front Oncol; 2021; 11():693394. PubMed ID: 34249747
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
Soares CD; de Lima Morais TM; Carlos R; Martins MD; de Almeida OP; Mariano FV; Altemani A
Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353
[TBL] [Abstract][Full Text] [Related]
35. [Predictive value of PD-L1 diagnostics].
Schildhaus HU
Pathologe; 2018 Nov; 39(6):498-519. PubMed ID: 30367225
[TBL] [Abstract][Full Text] [Related]
36. Medullary carcinoma of the ampulla has distinct clinicopathologic characteristics including common association with microsatellite instability and PD-L1 expression.
Xue Y; Balci S; Pehlivanoglu B; Muraki T; Memis B; Saka B; Kim G; Bandyopadhyay S; Knight J; El-Rayes B; Kooby D; Maithel SK; Sarmiento J; Basturk O; Reid MD; Adsay V
Hum Pathol; 2023 Jan; 131():38-46. PubMed ID: 36502926
[TBL] [Abstract][Full Text] [Related]
37. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors.
Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC
Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064
[TBL] [Abstract][Full Text] [Related]
38. Programmed death ligand 1 and CD8+ immune cell infiltrates in resected primary tracheal malignant neoplasms.
Tapias LF; Shih A; Mino-Kenudson M; Muniappan A; Gaissert HA; Lanuti M; Mathisen DJ; Ott HC
Eur J Cardiothorac Surg; 2019 Apr; 55(4):691-698. PubMed ID: 30418532
[TBL] [Abstract][Full Text] [Related]
39. Surgical Treatment of Carcinomas of the Oral Minor Salivary Glands-Oncological Outcome in Dependence of Tumor Entity and Therapeutic Strategies.
Moratin J; Horn D; Semmelmayer K; Ristow O; Engel M; Hoffmann J; Bleymehl M; Held T; Zittel S; Freudlsperger C
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568711
[TBL] [Abstract][Full Text] [Related]
40. [Malignant salivary gland tumors. Effect of histology and site on prognosis].
Chilla R; Casjens R; Eysholdt U; Droese M
HNO; 1983 Aug; 31(8):286-90. PubMed ID: 6629867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
